Proton Therapy for Sarcomas

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Journal

• Publication date

  2014-11-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1097/PPO.0000000000000084PMID 25415687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.

  2014cited by this paper
• Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas

  2014influential reference
• Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.

  2014cited by this paper
• Clinical Investigation : Late Effect Incidence of Second Malignancies Among Patients Treated With Proton Versus Photon Radiation

  2014influential reference
• Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Photon-based Fractionated Stereotactic Radiotherapy for Postoperative Treatment of Skull Base Chordomas

  2013cited by this paper
• Proton Radiation Therapy for Rhabdomyosarcoma: Preliminary Results From a Multicenter Prospective Study

  2013cited by this paper
• Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy

  2013cited by this paper
• Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.

  2012influential reference
• Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.

  2012cited by this paper
• Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes.

  2012influential reference
• The treatment outcome depending on the extent of resection in skull base and spinal chordomas

  2011cited by this paper
• Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.

  2011cited by this paper
• Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma

  2011cited by this paper
• Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's O

  2011cited by this paper
• A case study in proton pencil-beam scanning delivery.

  2010cited by this paper
• Spinal and paraspinal Ewing tumors.

  2010cited by this paper
• Proton-Beam, Intensity-Modulated, and/or Intraoperative Electron Radiation Therapy Combined with Aggressive Anterior Surgical Resection for Retroperitoneal Sarcomas

  2010cited by this paper
• Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.

  2009cited by this paper
• Osteosarcoma of the jaw/craniofacial region

  2009cited by this paper
• A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.

  2009influential reference
• Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.

  2009cited by this paper
• Efficacy of Proton Beam Therapy in the Treatment of Ewing's Sarcoma of the Paranasal Sinuses and Anterior Skull Base

  2009cited by this paper
• Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

  2009cited by this paper
• Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer institute.

  2008cited by this paper
• Gamma Knife surgery for skull base chordomas and chondrosarcomas.

  2007cited by this paper
• Extracranial chordoma: Outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation.

  2007cited by this paper
• Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience.

  2007influential reference
• Radiosurgery for chordomas and chondrosarcomas of the skull base.

  2007cited by this paper
• Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.

  2006cited by this paper
• Intensity-modulated radiation therapy, protons, and the risk of second cancers.

  2006cited by this paper
• Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.

  2005cited by this paper
• Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

  2005cited by this paper
• Radiosurgery for Cranial Base Chordomas and Chondrosarcomas

  2005cited by this paper
• Immunocytochemical characteristics of human osteosarcoma cell line HS-Os-1: possible implication in apoptotic resistance against irradiation.

  2004cited by this paper
• Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.

  2003cited by this paper
• Radiotherapy for local control of osteosarcoma.

  2003cited by this paper
• Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.

  2002cited by this paper
• Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors.

  2002cited by this paper
• Chordomas of the craniocervical junction: follow-up review and prognostic factors.

  2001cited by this paper
• Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base.

  2000cited by this paper
• Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma.

  2000cited by this paper
• Conventional external radiotherapy in the management of clivus chordomas with overt residual disease

  2000cited by this paper
• Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III

  1999cited by this paper
• Chordoma: long-term follow-up after radical photon irradiation.

  1996cited by this paper
• Cancer statistics

  1989cited by this paper
• Clinical and pathologic review of 48 cases of chordoma

  1985cited by this paper

• Advancements and applications in radiopharmaceutical therapy.

  2025cites this paper
• Evaluation of Treatment Modalities and Oncologic Outcomes in Hand Soft Tissue Sarcomas—A Systematic Review of the Literature

  2025cites this paper
• Proton beam radiation therapy vs. photon radiation therapy and the overall survival of adult and pediatric patients diagnosed with sarcoma

  2025cites this paper
• En bloc resection, including the cord for tumor-free margin, in a multilevel osteosarcoma of the spine: 20-year disease-free survival. Illustrative case

  2025cites this paper
• Cone-Beam CT Images as an Indicator of QACT During Adaptive Proton Therapy of Extremity Sarcomas

  2024cites this paper
• Proton Therapy for Spinal Tumors: A Consensus Statement from the Particle Therapy Cooperative Group.

  2024cites this paper
• Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma

  2023cites this paper
• Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study

  2022cites this paper
• Aktuelle Überlegungen zur System- und Lokaltherapie beim Ewing-Sarkom*

  2022cites this paper
• Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives

  2021cites this paper
• Managing axial bone sarcomas in childhood

  2021cites this paper
• Management of MPNST in Neurofibromatosis

  2021cites this paper
• Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture

  2020cites this paper
• Spindle Cell Sarcoma of the Maxilla: A Rare Entity, Case Report, and Review of the Literature.

  2020cites this paper
• Peripheral Nerve Tumors in Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis

  2020cites this paper
• Strahlentherapie nach Tumorendoprothesen – Stellenwert, Indikation, Koordination

  2019cites this paper
• Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma

  2019cites this paper
• Primary bone sarcomas

  2019cites this paper
• Chemotherapy in head and neck osteosarcoma: Adjuvant chemotherapy improves overall survival.

  2017cites this paper
• The Evolving Role of Proton Beam Therapy for Sarcomas.

  2017cites this paper
• Surgery Combined with Radiotherapy to Treat Spinal Tumors: A Review of Published Reports

  2016cites this paper
• Radiation Promotes Colorectal Cancer Initiation and Progression by Inducing Senescence-Associated Inflammatory Responses

  2015cites this paper